Evaluation of Torquetenovirus (TTV) Particle Integrity Utilizing PMAxx™.

Publication date: Jul 07, 2025

Open Access PDF

Concepts Keywords
Absent Adult
Covid Antibodies, Neutralizing
Immunosuppression Antibodies, Neutralizing
Liver Antibodies, Viral
Pcr Antibodies, Viral
COVID-19
COVID-19 vaccination
DNA, Viral
DNA, Viral
Female
genome quantification
HIV Infections
Humans
Immunoglobulin G
Immunoglobulin G
Male
Middle Aged
propidium monoazide (PMA)
SARS-CoV-2
Torque teno virus
Torquetenovirus
Viral Load
Viremia
Virion

Semantics

Type Source Name
disease MESH viral load
disease IDO immunosuppression
disease MESH viremia
disease MESH clinical relevance
pathway KEGG Virion
disease MESH COVID-19
drug DRUGBANK Belladonna
disease MESH Infectious Diseases
disease IDO blood
disease MESH Hepatitis
disease IDO replication
disease IDO host
disease IDO cell
disease MESH sepsis
disease MESH autoimmune diseases
pathway REACTOME Immune System
disease MESH Monkeypox
disease IDO assay
drug DRUGBANK Ilex paraguariensis leaf
drug DRUGBANK Ademetionine
drug DRUGBANK Aspartame
drug DRUGBANK Diethylpropion
disease MESH infections
drug DRUGBANK Cefalotin
disease IDO history
drug DRUGBANK Dimercaprol
disease IDO immunocompetence
drug DRUGBANK Hexachlorophene
disease MESH Melanoma
pathway KEGG Melanoma
disease IDO process
disease IDO infectivity
disease IDO infection
drug DRUGBANK Water
disease MESH Infectious Hepatitis
disease MESH Syndrome
disease MESH African Swine Fever
disease MESH Influenza
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Coenzyme M
pathway REACTOME Infectious disease
disease IDO infectious disease
disease MESH HIV Infections

Original Article

(Visited 10 times, 1 visits today)